Bispecific monoclonal antibodies, thrombolytic agent and method

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds hormone or other secreted growth regulatory factor,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241341, 4241361, 4241451, 4241821, 424 9463, 5303873, 5303881, 53038825, 5303917, A61K 5100, A61K 5110, A61K 3849, C07K 1638

Patent

active

054965497

ABSTRACT:
Disclosed are a bispecific hybrid MoAb having specificity for both an activated platelet and a substance having thrombolytic activity, and a thrombolytic agent comprising the above bispecific MoAb and a substance having thrombolytic activity immunologically bound thereto, whereby efficient, rapid thrombolysis is possible.

REFERENCES:
patent: 4474893 (1984-10-01), Reading
patent: 4714681 (1987-12-01), Reading
patent: 4734279 (1988-03-01), Stephan et al.
patent: 4889922 (1989-12-01), Schaumann et al.
Kurokawa, T. et al., Thrombosis Res, Supp X:83-89, Aug. 27, 1989.
Haber, E. et al., Science, 243:51-56, Jan. 6, 1989.
Milstein, C. et al., Immun. Today, 5(10):299-304, 1984.
Scheefers-Borchel, V. et al., PNAS, 82:7091-7095, Oct. 1985.
Kurokawa, T., et al., Biotechnology, 7:1163-1167, Nov. 1989.
Palabrica, et al., Proc. Natl. Acad. Sci. USA 86:1036-1040 (1989).
Bode, et al., The Journal of Biological Chemistry, 262(2):944-948 (1989).
McEver, Thrombosis and Haemostasis, 62:3 (1989).
Akamatu, et al., Thrombosis and Haemostasis, 62:250 (1989).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Bispecific monoclonal antibodies, thrombolytic agent and method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bispecific monoclonal antibodies, thrombolytic agent and method , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bispecific monoclonal antibodies, thrombolytic agent and method will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1411213

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.